Recent Activity

Loading...

CMPS

COMPASS Pathways Plc Sponsored ADR · NASDAQ

Performance

-0.82%

1W

-10.53%

1M

-19.96%

3M

+40.5%

6M

-2.86%

YTD

+0.47%

1Y

Profile

COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

Investment Analysis Report: CMPS

Overview:

CMPS is a company operating in the Health Technology sector, specifically in the Biotechnology industry. The company has a market capitalization of $650,532,572. In this report, we will conduct a comprehensive analysis of CMPS focusing on various perspectives including Valuation, Financial Health, Earni...

See more ...

Technical Analysis of CMPS 2024-05-03

Overview:

In analyzing the technical indicators for CMPS over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions for potential invest...

See more ...

Recent News & Updates